7,491.16

-58.78

-0.78%

52,113.99

-275.76

-0.53%

24,926.06

-327.08

-1.30%

2,808.34

-32.47

-1.14%

5.02

+0.15

+3.15%

20.47

+0.55

+2.76%

4,027.50

-87.00

-2.11%

73,000.51

-1,691.57

-2.26%

Crude Oil Dec 26

86.30

-0.55

-0.63%

US Private Equity

10,850.15

0.00

0.00%

NasdaqCM - Nasdaq Real Time Price USD

XTL Biopharmaceuticals Ltd. (XTLB)

1.6398 +0.1097 (+7.17%)

As of 11:42:06 AM EST. Market Open.

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

XTL Completed the Acquisition of Psyga Bio Ltd.

GlobeNewswire 4mo ago

XTLB
+7.17%
XTL Announces Receipt of Staff Delist Determination from Nasdaq

GlobeNewswire 5mo ago

^IXIC

XTLB
+7.17%
XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies

GlobeNewswire 6mo ago

XTLB
+7.17%
XTL Biopharmaceuticals Announces ADS Ratio Change

GlobeNewswire 7mo ago
XTL Update on Recent Developments

GlobeNewswire 9mo ago

XTLB
+7.17%
XAIR
XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

GlobeNewswire 9mo ago

XTLB
+7.17%
XAIR
XTL Biopharmaceuticals Acquires 85% of Beyond Air’s Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

GlobeNewswire 9mo ago

XAIR

XTLB
+7.17%
XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

GlobeNewswire 10mo ago

XTLB
+7.17%
^IXIC

Performance Overview

Return	XTLB	TA-125 (^TA125.TA)
YTD	-41.44%	+8.83%
1-Year	-59.01%	+16.19%
3-Year	-51.77%	--

Mobilize your Website

View Site in Mobile | Classic

Share by: